Cargando…
CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis
Poor clinical outcome of lung cancer (LuCa) is primarily due to lack of knowledge about specific molecules involved in its progression and metastasis. In this study, we for the first time show the clinical and biological significance of CC chemokine receptor-9 (CCR9) in non-small cell lung cancer (N...
Autores principales: | Gupta, Pranav, Sharma, Praveen K., Mir, Hina, Singh, Rajesh, Singh, Nalinaksha, Kloecker, Goetz H., Lillard, James W., Singh, Shailesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259413/ https://www.ncbi.nlm.nih.gov/pubmed/25296976 |
Ejemplares similares
-
CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases
por: Mir, Hina, et al.
Publicado: (2015) -
CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and α(v)β(3) integrin clustering
por: Singh, Rajesh, et al.
Publicado: (2016) -
Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma
por: SINGH, RAJESH, et al.
Publicado: (2014) -
CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion
por: Johnson, Erica L, et al.
Publicado: (2010) -
CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion
por: Johnson-Holiday, Crystal, et al.
Publicado: (2011)